Beryl Drugs informs about unaudited financial results

14 Mar 2018 Evaluate

Beryl Drugs has informed about resubmission of unaudited financial results for the quarter ended 30th June, 2017 as per schedule III of companies act, 2013.

The above information is a part of company’s filings submitted to BSE.

Beryl Drugs Share Price

22.50 0.25 (1.12%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×